Monday, 26 August 2019

Dr. Reddy's announces launch of Ramelteon Tablets in the U.S. Market

23 July 2019 | News

Dr. Reddy’s Ramelteon Tablets are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000

Dr. Reddy’s Laboratories Ltd. has announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem® (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The Rozerem® brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019 according to IQVIA Health.

Dr. Reddy’s Ramelteon Tablets are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000.

Rozerem® is a trademark of Takeda Pharmaceutical Company Limited.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls